Inventor · disambiguated record
Niels Christoph Riedemann
Also filed as: RIEDEMANN NIELS C · RIEDEMANN NIELS CHRISTOPH
12 granted patents·2 pending applications·86 citations·filing 2003–2024
90Inventor score
Top patents by PatentIndex Score
14 records- 0195US11149009B2Fused piperidinyl bicyclic and related compounds as modulators of C5A receptorINFLARX GMBH·Filed 2020·Granted Oct 19, 2021·4 cites·2 claims
- 0294US10376595B2Treatment of inflammatory diseases with inhibitors of C5a activityINFLARX GMBH·Filed 2018·Granted Aug 13, 2019·8 cites·19 claims
- 0392US10774136B2Anti-C5a binding moieties with high blocking activityINFLARX GMBH·Filed 2016·Granted Sep 15, 2020·5 cites·10 claims
- 0492US9458233B2Anti-C5a binding moieties with high blocking activityINFLARX GMBH·Filed 2015·Granted Oct 4, 2016·12 cites·28 claims
- 0591US12180274B2Treatment of pneumonia and ARDS with inhibitors of C5a and IL-6 activityINFLARX GMBH·Filed 2023·Granted Dec 31, 2024·1 cites·4 claims
- 0690US11464868B2Treatment of inflammatory diseases with inhibitors of C5A activityINFLARX GMBH·Filed 2019·Granted Oct 11, 2022·4 cites·7 claims
- 0790US8802096B2Anti-C5a binding antibodies with high block activityGUO RENFENG·Filed 2010·Granted Aug 12, 2014·22 cites·15 claims
- 0883US7455837B2Compositions and methods for the diagnosis and treatment of sepsisUNIV MICHIGAN·Filed 2003·Granted Nov 25, 2008·29 cites·2 claims
- 0977US2024300898A1Fused piperidinyl bicyclic and related compounds as modulators of c5a receptorINFLARX GMBH·Filed 2024·Application pending·0 cites
- 1070US11890349B2Treatment of inflammatory diseases with inhibitors of C5A activityINFLARX GMBH·Filed 2020·Granted Feb 6, 2024·0 cites·2 claims
- 1169US11999698B2Fused piperidinyl bicyclic and related compounds as modulators of C5a receptorINFLARX GMBH·Filed 2021·Granted Jun 4, 2024·0 cites·14 claims
- 1269US10227397B2Inhibitors of C5a for the treatment of viral pneumoniaINFLARX GMBH·Filed 2015·Granted Mar 12, 2019·1 cites·6 claims
- 1362US10858421B2Inhibitors of C5A for the treatment of viral pneumoniaINFLARX GMBH·Filed 2019·Granted Dec 8, 2020·0 cites·13 claims
- 1448US2023158060A1Inhibitors of C5a for the Treatment of Corona Virus InfectionINFLARX GMBH·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →